blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0442769

EP0442769 - Compounds destined for encapsulation in erythrocytes, new derivatives of naloxone and naltrexone [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.12.1994
Database last updated on 21.05.2024
Most recent event   Tooltip07.12.1994Application deemed to be withdrawnpublished on 25.01.1995 [1995/04]
Applicant(s)For all designated states
FONDATION NATIONALE DE TRANSFUSION SANGUINE
6, rue Alexandre Cabanel
75739 Paris Cédex 15 / FR
[N/P]
Former [1991/34]For all designated states
FONDATION NATIONALE DE TRANSFUSION SANGUINE
6, rue Alexandre Cabanel
F-75739 Paris Cédex 15 / FR
Inventor(s)01 / Guillaumet, Gérald
2 rue A. Renoir
F-45100 Orléans / FR
02 / Ropars, Claude
16 rue de la Pinterie
F-37550 St Avertin / FR
03 / Meunier, Jean-Claude
8 Chemin du Pin, Rebigue
F-31320 Castanet Tolosan / FR
[1991/34]
Representative(s)Warcoin, Jacques, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [1991/34]Warcoin, Jacques, et al
Cabinet Régimbeau, 26, avenue Kléber
F-75116 Paris / FR
Application number, filing date91400127.621.01.1991
[1991/34]
Priority number, dateFR1990000061319.01.1990         Original published format: FR 9000613
[1991/34]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report 
No.:EP0442769
Date:21.08.1991
Language:FR
[1991/34]
Type: A3 Search report 
No.:EP0442769
Date:12.02.1992
Language:FR
[1992/07]
Search report(s)(Supplementary) European search report - dispatched on:EP19.12.1991
ClassificationIPC:C07D489/08, C07F9/6561, A61K31/485
[1991/34]
CPC:
C07D489/08 (EP); A61K9/5068 (EP); C07F9/6561 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1991/34]
TitleGerman:Verbindungen bestimmt zur Verkapselung in Erythrocyten, neue Naloxone- und Naltrexone-Derivate[1991/34]
English:Compounds destined for encapsulation in erythrocytes, new derivatives of naloxone and naltrexone[1991/34]
French:Composés destinés à l'encapsulation dans les érythrocytes-nouveaux dérivés de la naloxone et naltrexone[1991/34]
File destroyed:15.01.2000
Examination procedure05.08.1992Examination requested  [1992/40]
13.04.1994Despatch of a communication from the examining division (Time limit: M04)
02.08.1994Application deemed to be withdrawn, date of legal effect  [1995/04]
30.08.1994Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [1995/04]
Fees paidRenewal fee
18.01.1993Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.01.199404   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US4673679
 [XD]  - JOURNAL OF MEDICINAL CHEMISTRY. vol. 16, no. 5, 1973, WASHINGTON US pages 553 - 556; CHARLES LINDER ET AL.: 'Narcotic antagonists. 1.Isomeric sulfate and acetate esters of naloxone ( N-allylnoroxymorphone)'
 [X]  - CHEMICAL ABSTRACTS, vol. 84, 1976, Columbus, Ohio, US; abstract no. 130074X, MISRA A.L. ET AL.: 'Physiological disposition and biotransformation of ( allyl-1',3'-14C) naloxone in the rat and some comparative observations on malorphine.' page 6 ;
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.